ODDB.org: Open Drug Database

Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Sevre-Long 120 mg, Kapseln retard

Swissmedic Registration	53952	Sequence	04
Product name	Sevre-Long 120 mg	Description	Kapseln retard
ATC-Classification	N02AA01	ATC-Description	Morphine
Introduction of Sequence	30.01.1997

Composition

morphini sulfas pentahydricus 120 mg corresp. morphinum 90.25 mg, oleum vegetabile hydrogenatum, macrogolum 6000, talcum, magnesii stearas, Kapselhülle: E 132, E 172 (nigrum), E 172 (flavum), E 171, natrii laurilsulfas corresp. natrium 0.012 mg, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.

Packungsbestandteile

Galenic Form

Delayed release capsules

Active Agent	Dose
Morphine Sulfate Pentahydrate	120 mg correspond Morphine 90.25 mg

BAG: Active Agent	Dose
	120 mg

Inactive agents	Dose	additional_information


		Kapselhülle
		color.
		color.
Gelatina
		Drucktinte
Macrogol	6000




Propylenglycol
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	100 Capsule(s)	172.64	204.15	A+	SL	No
046	30 Capsule(s)	54.52	75.70	A+	SL	No

2025	©ywesee GmbH